CryoLife to Receive $2.25 Million to Settle Dispute
Steven G. Anderson, President and Chief Executive Officer stated, "We believe that the settlement of this dispute was in the best interests of our shareholders and are pleased to have this matter behind us. The settlement strengthens our financial position and reinforces our belief that we will not have to complete a financing to fund our day-to-day operations."
Investors and other interested parties are referred to the Company's Form 8-K filed with the Securities and Exchange Commission on September 29, 2006.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.